Clinical trials
Observational Multiple Sclerosis trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 2 |
| 2007 | 3 |
| 2009 | 3 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 37 |
| Recruiting | 9 |
| Unknown status | 7 |
| Terminated | 3 |
| Enrolling by invitation | 2 |
| Active, not recruiting | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 15 |
| Bayer | 11 |
| Charite University, Berlin, Germany | 5 |
| Heinrich-Heine University, Duesseldorf | 4 |
| Novartis Pharmaceuticals | 4 |
| Universitätsklinikum Hamburg-Eppendorf | 3 |
| Bristol-Myers Squibb | 2 |
| Hoffmann-La Roche | 2 |
| Merck KGaA, Darmstadt, Germany | 2 |
| icometrix | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 61 |
| Multiple Sclerosis, Relapsing-Remitting | 10 |
| Multiple Sclerosis, Chronic Progressive | 4 |
| Disease Progression | 3 |
| Carcinoma in Situ | 2 |
| Fatigue | 2 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 2 |
| Demyelinating Diseases | 1 |
| Disease | 1 |
| Fatigue Syndrome, Chronic | 1 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.